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Roy C, Paglialunga S, Fisette A, Schrauwen P, Moonen-
Kornips E, St-Onge J, Hesselink MK, Richard D, Joanisse DR,
Cianflone K. Shift in metabolic fuel in acylation-stimulating
protein-deficient mice following a high-fat diet. Am J Physiol
Endocrinol Metab 294: E1051–E1059, 2008. First published April
8, 2008; doi:10.1152/ajpendo.00689.2007.—ASP-deficient mice
(C3 KO) have delayed postprandial TG clearance, are hyperphagic,
and display increased energy expenditure. Markers of carbohydrate
and fatty acid metabolism in the skeletal muscle and heart were
examined to evaluate the mechanism. On a high-fat diet, compared
with wild-type mice, C3 KO mice have increased energy expenditure,
decreased RQ, lower ex vivo glucose oxidation (39%, P  0.018),
and higher ex vivo fatty acid oxidation (68%, P  0.019). They
have lower muscle glycogen content (25%, P  0.05) and lower
activities for the glycolytic enzymes glycogen phosphorylase (31%,
P  0.005), hexokinase (43%, P  0.007), phosphofructokinase
(51%, P  0.0001), and GAPDH (15%, P  0.04). Analysis of
mitochondrial enzyme activities revealed that hydroxyacyl-coenzyme
A dehydrogenase was higher (25%, P  0.004) in C3 KO mice.
Furthermore, Western blot analysis of muscle revealed significantly
higher fatty acid transporter CD36 (40%, P  0.006) and cyto-
chrome c (a marker of mitochondrial content; 69%, P  0.034)
levels in C3 KO mice, whereas the activity of AMP kinase was lower
(48%, P  0.003). Overall, these results demonstrate a shift in the
metabolic potential of skeletal muscle toward increased fatty acid
utilization. Whether this is 1) a consequence of decreased adipose
tissue storage with repartitioning toward muscle or 2) a direct result of
the absence of ASP interaction with the receptor C5L2 in muscle
remains to be determined. However, these in vivo data suggest that
ASP inhibition could be a potentially viable approach in correcting
muscle metabolic dysfunction in obesity.
muscle metabolism; glycolysis; -oxidation; C3adesArg
ACYLATION-STIMULATING PROTEIN (ASP) is produced by adipo-
cytes through the alternative complement pathway. C3, factor
B, and adipsin associate to generate C3a, and the COOH-
terminal arginine of C3a is then cleaved rapidly by car-
boxypeptidase B to produce ASP (C3adesArg) (reviewed in
Ref. 4). ASP interacts with its cell surface receptor, C5L2,
resulting in increased nonesterified fatty acid (NEFA) uptake
and increased triglyceride synthesis through stimulation of
diacylglycerol acyltransferase activity (40). ASP, through its
effects on triglyceride synthesis, indirectly stimulates lipopro-
tein lipase activity (11). ASP also increases glucose uptake in
a number of cell models, including human adipocytes and L6
myotubes via glucose transporter GLUT4 and GLUT3 (in
myotubes) translocation to the cell surface (14, 21, 34). On the
other hand, ASP inhibits the action of hormone-sensitive lipase
(36), effectively enhancing intracellular triglyceride (TG) ac-
cumulation. We have shown previously that ASP-deficient
mice [C3 knockout (KO)] are leaner with reduced adipose
tissue mass and decreased leptin levels (22). We also observed
delayed postprandial TG and NEFA clearance after a fat load
in both young and old ASP-deficient mice (23, 24). Further-
more, injection of exogenous ASP in ASP-deficient mice
before a fatload normalized the TG and NEFA clearance (39).
Interestingly, despite being leaner, C3 KO mice had a
significant increase in food intake, which was counterbalanced
by increased oxygen consumption, and elevated muscle fatty
acid uptake and oxidation. ASP injection in ASP-deficient
mice restored fat partitioning toward a wild-type (WT) profile
(39). In addition, we recently showed that mice lacking the
ASP receptor C5L2 (C5L2 KO) demonstrated a phenotype
similar to ASP-deficient mice with delayed postprandial TG
clearance, increased dietary intake, and increased muscle fatty
acid oxidation (28). Kalant and colleagues (18, 19) demon-
strated that C5L2, a G protein-coupled receptor, is a functional
ASP receptor. The relation between ASP and C5L2 was
demonstrated through gain-of-function (stable transfection)
and loss-of-function (antisense and siRNA) assays, which
demonstrated that the presence of C5L2 was essential in
mediating ASP function (19). The aim of the present study was
to identify the mechanism of increased energy expenditure and
fat repartitioning in the C3 KO mice and to evaluate the role of
muscle, heart, and brown adipose tissue (BAT) in mediating
these effects.
MATERIALS AND METHODS
Mice. C3 KO mice were generously donated by Dr. M. Pekna (29).
C3 KO mice were on a C57Bl/6 background and had been back-
crossed for at least eight generations, and they were bred in our
facility concurrently with WT C57Bl/6 mice. Mice were maintained in
a sterile barrier facility under a 12:12-h light-dark cycle and housed
individually. At 8 wk, mice were placed on either a standard low-fat
(LF) diet (10% kcal from fat; Charles River Laboratories) or a high-fat
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(HF) diet (45% kcal from fat; Research Diets, New Brunswick, NJ)
for 12 wk. Food intake and body weight were measured every 2 days
for 12 wk. For each mouse, cumulative caloric intake per body weight
was calculated. Results are expressed as an average for WT and KO
mice. Six to eight mice per group were used for food intake, plasma
analysis, Western blot, and enzyme activity assays. A second set of
mice, seven per group, placed on the HF diet for 3 wk were used for
indirect calorimetry experiments and ex vivo tissue assays. A third
subset of mice (four C3 KO mice) was used in a pair-feeding study.
C3 KO pair-fed mice on the HF diet were food restricted to
consume the same amount as WT (3.4 g/day) for 12 wk. All protocols
were conducted in accordance with the guidelines of and approved by the
Canadian Council on Animal Care and the University Animal Care
Committee at Université Laval.
Chemicals. [-32P]ATP, [14C(U)]glucose, and [9,10-3H(N)]palmitic
acid were obtained from PerkinElmer Life Science (Boston, MA), and
all other biochemicals were from Sigma-Aldrich (St. Louis, MO) or
Roche Diagnostics (Laval, QC, Canada) unless otherwise specified.
Indirect calorimetry. Oxygen consumption (V̇O2), carbon dioxide
production (V̇CO2), and the respiratory quotient (RQ) were measured
over a 24-h period in an open-circuit system with an S-3A1 oxygen
analyzer and a CD-3A carbon dioxide analyzer (both from Applied
Electrochemistry, Pittsburgh, PA). V̇O2 and V̇CO2 were calculated as
milliliters per minute, and RQ was taken as the quotient of V̇CO2/V̇O2.
Plasma assays and glucose tolerance test. Overnight-fasted 18-wk-
old mice were injected intraperitoneally with glucose (2 mg/g body wt
in 200 l of sterile solution). Blood samples were taken at 0, 30, 60,
and 120 min after the injection by tail vein bleeding. Samples were
collected in 2% EDTA, and plasma was separated by centrifugation at
5,000 g for 5 min and stored at 20°C. Plasma glucose was measured
using a glucose Trinder assay (Sigma). At the time the mice were
killed, fasting blood samples were taken by cardiac puncture. Muscle,
heart, and brown fat were excised from the mice, weighed, and
immediately placed in liquid nitrogen and stored at 80°C until
further use. Insulin, leptin, and adiponectin were measured using
commercially available RIA kits from Linco (St. Charles, MO).
Plasma TG and NEFA were measured using enzymatic colorimetric
kits from Roche Diagnostics (Indianapolis, IN) and Wako Chemical
(Richmond, VA), respectively.
Skeletal muscle and heart glucose and fatty acid oxidation.
[14C]glucose oxidation was measured by capturing 14CO2 secreted
into the medium as described previously, with some modification
(10). Briefly, skeletal muscle (quadriceps) and heart were collected
after the mice were killed and placed in room-temperature PBS. The
tissue was cut into small pieces (10–20 mg) and placed into a glass
culture tube with Ca2-free Krebs-Ringer buffer (500 ul) containing
1% BSA and 5 mM glucose {[14C(U)]glucose, 1 mCi/ml}. A piece of
filter paper was hung vertically above the reaction solution and fixed
to a rubber stopper. The tubes were capped and incubated for 2 h at
37°C. Following the incubation, the filter paper was saturated with a
base (CO2 trapping agent), and 200 ul of 4 M H2SO4 was injected into
the medium of each tube (not touching the saturation paper). The
tubes were then incubated for an additional 1 h at 37°C with gentle
shaking to release 14CO2. The filter papers with captured 14CO2
were transferred to scintillation tubes and counted. The remaining
media were carefully removed, and 0.3 N NaOH was added to the
tissue to dissolve proteins. Proteins were measured by Bradford
method (Bio-Rad, Mississauga, ON, Canada), and results are
expressed as picomoles per milligram of protein. Fatty acid oxi-
dation was measured using radiolabeled palmitate as described
previously (28).
Western blot. Frozen quadriceps muscle was homogenized in lysis
buffer (1 mM EDTA, 0.4 mM phenylmethylsulphonyl fluoride in
PBS), SDS gel sample buffer was added, and protein homogenates
were separated by electrophoresis on a 12% acrylamide-bis gel at 200
V for 45 min. Proteins were transferred via electroblotting (60 min at
100 V) onto a nitrocellulose membrane. Peroxisome proliferator-
axctivated receptor- (PPAR) and mitochondrial transcription factor
A (mtTFA) were visualized with the Odyssey (LI-COR Biotechnol-
ogy, Lincoln, NE) imaging system. Primary antibody PPAR sc-7197
rabbit polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA) and
secondary donkey anti-rabbit IR800 (Rockland Immunochemicals,
Gilbertsville, PA) and primary mtTFA sc-19050 goat polyclonal
(Santa Cruz) and secondary donkey anti-goat Alexa 680 (Molecular
Probes, Eugene, OR) were used for detecting PPAR and mtTFA,
respectively. For the evaluation of CD36, cytochrome c content, and
uncoupling protein 3 (UCP3), blocking, antibody incubation, and
visualization procedures were followed as previously described by
Paglialunga et al. (28).
Quadriceps muscle and heart metabolic enzyme activity assays.
Muscles were maintained frozen at 80°C until assayed for maximal
(Vmax) enzyme activities. The muscle samples were pulverized into
powder to avoid possible variability caused by fiber-type distribution.
Approximately 10 mg of muscle powder was homogenized (1:40
wt/vol for quadriceps, 1:80 wt/vol for heart) with a glass-on-glass
Duall homogenizer with ice-cold buffer (0.1 M phosphate buffer, 2
mM EDTA, 1 mM PMSF, pH 7.2). The homogenate was transferred
into 1.5-ml polypropylene microtubes and sonicated six times for 5 s
at 20 W, on ice, with pauses of 85 s between pulses. Activities of the
following enzymes were measured as described previously in detail
(8, 12). Potential for glycogenolysis was assessed as the activity of
glycogen phosphorylase (PHOS). For glycolysis, hexokinase (HK)
and phosphofructokinase (PFK) were measured, as was hydroxyacyl-
CoA dehydrogenase (HADH) for fatty acid -oxidation. For assess-
ment of high-energy phosphate metabolism, citric acid cycle, and
evaluation of the respiratory chain potentials, creatine kinase (CK),
citrate synthase (CS), and cytochrome c oxidase (COX), respectively,
were measured. For carnitine palmitoyltransferase I (CPT I), the
sonicated homogenate was used for spectrophotometric determination
of CPT I by following the appearance of CoASH at 412 nm as
described previously (8, 12). Enzyme activities are expressed as
micromoles of substrate consumed per minute per gram of wet tissue
(mol min1 g1). The ratios of PFK to CS, PFK to HADH, and
PFK to COX were used as indicators of the relative capacity for
glycolytic to aerobic metabolism. Glycogen content was measured
with a spectrophotometer as described previously (16).
Quadriceps muscle and cardiac muscle AMP-activated protein
kinase activity assay. The AMP-activated protein kinase (AMPK)
activity protocol as published by Sambandam et al. (33) was modified
as described previously by Paglialunga et al. (28). Briefly, 20 mg of
frozen skeletal muscle (quadriceps) was homogenized for 30 s in 200
l of homogenization buffer [50 mM Tris HCl, pH 8, 1 mM EDTA,
10% (wt/vol) glycerol, 0.02% (vol/vol) Brij-35, 1 mM dithiothreitol]
with protease and phosphatase inhibitors. The homogenate was cen-
trifuged at 10 000 g for 20 min at 4°C, and protein content was
measured using the Bradford assay (Bio-Rad). AMPK activity was
measured by following the incorporation of [-32P] into the synthetic
peptide AMARA {final volume 25 l, containing 80 mM HEPES-
NaOH, pH 7.0, 160 mM NaCl, 16% glycerol, 1.6 mM EDTA, 200 M
AMARA peptide, 1 mM MgCl2, 2 mM [-32P]ATP (400–600 dpm/
pmol), and 5 g of protein homogenate; AMARAASAAALARRR;
Upstate, Billerica, MA}. The assay was performed in the absence (for
nonspecific background) or presence of AMARA at 30°C for 15 min.
Following incubation, 10-l aliquots were spotted on P81 phospho-
cellulose paper (Whatman, Florham Park, NJ), washed with 1%
H3PO4, and counted with 5 ml of scintillation fluid.
Statistical analysis. Results are presented as means  SE, except
for food intake data, which are presented as means  SD. Groups
were compared with two-way repeated-measures ANOVA, ANOVA,
and Student’s t-test as appropriate. Statistical significance was set as
P  0.05.
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RESULTS
We first measured food intake relative to body weight over
a 10-wk period in C3 KO and WT mice. The C3 KO mice,
compared with the WT counterparts, had a 59% increase (P 
0.0001) on the LF diet (Fig. 1A) and a dramatic 229% increase
(P  0.0001) on the HF diet (Fig. 1B) in cumulative food
intake. Interestingly, there was no difference in body weight
between WT and C3 KO on either diet during the 10 wk of the
experiment, as shown in Table 1. It was shown previously that
increased physical activity or changes in body temperature
could not adequately explain this imbalance between food
intake and body weight observed in C3 KO mice on the LF diet
(39). In the present study, C3 KO and WT mice were placed in
a metabolic chamber to measure indirect calorimetry after 2 wk
on the HF diet. The C3 KO mice displayed a higher V̇O2
consumption than the WT mice, indicating elevated energy
expenditure (P  0.0001; Fig. 1C). Also, the C3 KO mice
showed a lower RQ compared with their WT counterparts (P 
0.0017; Fig. 1D). Taken together, these results imply a differ-
ence in energy expenditure and preference for dietary fat as an
energy substrate, which was then related to the metabolic
machinery of various target tissues, including BAT, skeletal
muscle, and cardiac muscle.
Plasma analysis and brown fat. BAT mass was measured
following 12 wk on a LF or HF diet. At the time the mice were
killed, no significant differences in BAT weight between WT
and C3 KO mice on either diet were observed (data not
shown). Fasting plasma values were measured for the four
groups of mice (Table 1). Levels of insulin, leptin, and adi-
ponectin, hormones known to influence energy storage, food
intake, and energy expenditure, were not different when the C3
KO mice were compared with the WT mice under the same
diet (Table 1). On the LF diet only, the plasma TG levels were
significantly higher in the C3 KO mice. Interestingly, on the
HF diet, fasting plasma TG, NEFA, and glucose were elevated
in C3 KO compared with WT mice (P  0.05).
Glucose uptake and glycogen stores in skeletal muscle. To
evaluate the implication of elevated plasma glucose observed
in C3 KO on a HF diet, glucose handling, glycogen content,
and variations in maximal activities of key skeletal muscle
glycolytic enzymes were measured in the quadriceps muscles
of WT and C3 KO mice following LF or HF diets.
Following the HF diet, the C3 KO mice showed a slight, but
not significant, delay in glucose clearance compared with
controls (data not shown). Several changes in ex vivo glucose
metabolism were found in the C3 KO vs. the WT mice on the
HF diet. First, C3 KO mice showed lower ex vivo glucose
oxidation in quadriceps muscle (P  0.018; Fig. 2A). Second,
the C3 KO mice had a 25% decrease in skeletal muscle
glycogen content (P  0.01; Fig. 2B). Last, the C3 KO mice
showed significantly lower maximal activities for key enzymes
of glucose and glycogen utilization. There was a 31% decrease
in PHOS activity (P  0.005; Fig. 2C), a key enzyme for
Table 1. Body weight and fasting plasma values of WT
and C3 KO mice on LF and HF diets
WT LF C3 KO LF WT HF C3 KO HF
Body weight, g 30.90.6 32.71.8 38.11.1 40.41.4
Leptin, ng/ml 5.890.92 8.581.83 15.543.93 22.974.92
Adiponectin, g/ml 12.321.86 6.641.19 13.882.11 13.132.72
Insulin, ng/ml 0.280.06 0.350.08 0.450.09 0.680.22
TG, mmol/l 0.230.05 0.410.05* 0.250.06 0.580.06†
NEFA, mmol/l 0.630.06 0.820.16 0.570.07 1.170.23*
Glucose, mmol/l 5.820.15 6.130.40 5.410.32 7.72.77*
Results are expressed as means  SE for 6–8 mice. WT, wild type; C3 KO,
acylation protein-deficient mice; LF, low fat; HF, high fat; TG, triglycerides;
NEFA, nonesterified fatty acids. Statistical significance was evaluated by
2-way ANOVA comparing WT vs. KO, where *P  0.01 and †P  0.001.
Fig. 1. Increased food intake, energy expen-
diture, and lower respiratory quotient (RQ) in
acylation-stimulating protein (ASP)-deficient
(C3 KO) mice. Food intake is increased with-
out changes in body weight in C3 KO mice
vs. wild-type (WT) mice on a low-fat (LF)
diet (A) and on a high-fat (HF) diet (B). Food
intake was measured 2–3 times weekly and
was assessed for each mouse individually.
Food intake (means  SD) is expressed as
kcal consumed/mouse. Cumulative food in-
take was measured over a 10-wk period for
WT mice () and C3 KO mice (F); n  6–8
mice/group. Oxygen consumption and RQ
were measured following 2 wk on a HF diet.
C3 KO mice have an elevated oxygen con-
sumption (V̇O2; C) and a lower RQ (D). V̇O2,
carbon dioxide production (V̇CO2), and RQ
were measured over 24 h. Results are ex-
pressed as means  SE for WT mice () and
C3 KO mice (F); n  6–8 mice/group. Sig-
nificance was determined by 2-way repeated-
measures ANOVA, where *P  0.05 and
***P  0.0001.
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breakdown of glycogen to glucose. HK activity, which regu-
lates glucose phosphorylation for entry into glycolysis, was
decreased by 45% (P  0.007; Fig. 2D). Furthermore, a 51%
decrease in PFK activity, the rate-limiting enzyme for glycol-
ysis (P  0.0001; Fig. 2E), was also demonstrated. Glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) activity, an en-
zyme controlling glucose entry into the citric acid cycle, was
decreased by 15% (P  0.04; Fig. 2F).
On the LF diet, C3 KO mice maintained fasting glucose
levels comparable with WT mice (Table 1), yet they showed a
significantly delayed glucose clearance (incremental area under
the curve for WT LF: 11.9  2.6 mmol  l1 min1, and C3 KO
LF: 20.4  1.4 mmol  l1 min1, P  0.017), a 49% decrease
in muscle glycogen content (P  0.009; Table 2), and a
significantly higher PFK activity compared with their WT
counterparts.
Fatty acid handling in the skeletal muscle. In addition to
glucose oxidation, palmitate metabolism was also evaluated in
the quadriceps muscle. In relation to the WT mice, ex vivo
fatty acid oxidation in the C3 KO mice was significantly
increased (P  0.019; Fig. 3A). Proteins involved in fatty acid
channelling in the skeletal muscle were also evaluated. We
observed 40% more skeletal muscle CD36 protein content, a
key membrane fatty acid transporter, in the C3 KO mice
relative to the WT mice on the HF diet (P  0.006; Fig. 3B).
The activity of CPT I, the rate-limiting step of fatty acid entry
into mitochondria, was also assayed. As shown in Fig. 3C, no
significant difference was detected between the WT and C3
KO mice on a HF diet. No change was detected in UCP3 (see
results below). No significant differences were observed on the
LF diet for either CD36 or CPT I (Table 2).
Mitochondrial enzyme activities and proteins in skeletal
muscle. A number of mitochondrial enzyme activities were
assayed. Results showed a 25% increase in HADH activity, a
key enzyme in -oxidation (P  0.004; Fig. 4A), and a 69%
increase in cytochrome c content, which is indicative of cellu-
lar mitochondrial content (P  0.034; Fig. 4B) in C3 KO mice
compared with the WT mice on the HF diet. Interestingly, there
were also greater activities of two mitochondrial enzymes
assayed in the mice muscle from animals on the LF diet; C3
KO mice presented a 42% increase in HADH (Table 2) and a
43% increase in CS activity compared with the WT mice (P 
0.025; Table 2). The cytochrome c upregulation indicates that
the mitochondrial biogenesis pathway could be affected. To
clarify this, we assessed mtTFA and PPAR protein content
via Western blot. There was no significant change in mtTFA or
PPAR content between the C3 KO mice and their WT
counterparts (Fig. 6D), indicating that increased mitochondrial
Fig. 2. C3 KO mice on a HF diet have de-
creased skeletal muscle ex vivo glucose oxida-
tion and a reduced potential for glycolysis, as
assessed by ex vivo glucose oxidation (A), mus-
cle glycogen content (B), and glycogen phos-
phorylase (PHOS; C), hexokinase (HK; D),
phosphofructokinase (PFK; E), and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH; F)
activities. Ex vivo glucose oxidation was mea-
sured in quadriceps muscle pieces, whereas en-
zyme activities were assessed in quadriceps
muscle homogenates derived from WT (open
bars) and C3 KO (black bars) mice on a HF
diet. Results are expressed as means  SE for
6–8 mice/group, where *P  0.05, **P 
0.01, and ***P  0.001.
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biogenesis was not the major mechanism for the increase in
mitochondrial activity.
The ratio of key enzymes involved in fuel utilization was used
as an indicator of the relative maximal potential of different
metabolic pathways within the muscle. The ratio of PFK activity
(the rate-limiting enzyme in glycolysis) to HADH, CS, and
cytochrome oxidase activities is reported in Table 3. C3 KO mice
on the HF diet show a significant decrease in the PFK/HADH
ratio (Fig. 4C). The ratios shown in Table 3 report an overall,
but nonsignificant, decrease in PFK/CS and PFK/COX in C3
KO mice on the HF diet.
Muscle fuel metabolism. Skeletal muscle assays revealed
significantly lower activities of two enzymes involved in the
energy metabolism in the C3 KO mice. On the HF diet, AMPK
activity was reduced by 48% (P  0.003; Fig. 5A) in the C3
KO mice compared with the WT mice. Also, on the same diet,
we observed a 45% decrease in CK maximal activity in the C3
KO mice (P  0.0001; Fig. 5B). Interestingly, this decrease in
enzyme activity was specific to C3 KO mice on the HF diet, as
there were no significant differences between C3 KO and WT
mice on the LF diet (Table 2).
Studies on pair-fed mice. A subset of C3 KO mice were
pair-fed a HF diet for 12 wk matched to the food intake of their
WT counterparts, thereby controlling for the hyperphagia of
the C3 KO mice. As shown in Fig. 6A, the pair-fed C3 KO
mice had a lower body weight than the WT mice. Compared
with their WT counterparts, the pair-fed C3 KO mice displayed
significantly lower levels of plasma insulin and adiponectin
(Fig. 6, B and C). They also had higher UCP3 and cytochrome
c protein levels as assayed by Western Blot (Fig. 6D).
Cardiac muscle. In our previous and present studies, C3 KO
mice did not display any obvious functional or morphological
changes in cardiac muscle such as heart size, lipid deposits, or
sudden death (Roy C, personal observations). In the present
study, heart (cardiac) tissue was evaluated to determine any
similarities with the skeletal muscle for the modified substrate
utilization documented above. Cardiac muscle was used to
evaluate ex vivo oxidation and maximal activities for key
regulators of glucose and fatty acid oxidation on a HF diet.
Although there were significant differences between C3 KO
and WT mice in skeletal muscle for both substrate oxidations,
there was no difference in ex vivo glucose oxidation in cardiac
tissue (Fig. 7A), but there was a significant increase in ex vivo
fatty acid oxidation (P  0.04; Fig. 7B). On the HF diet, C3
KO mice displayed significant changes in enzyme activities
(Fig. 7). Similar to skeletal muscle, in C3 KO mice on the HF
diet, cardiac CK activity was decreased by 42% (P  0.036;
Fig. 7C) and AMPK activity was decreased by 45% (P 
0.025; Fig. 7D). CPT I activity was decreased by 46% (P 
0.008; Fig. 7E), and GAPDH activity was increased by 45%
(P  0.010; Fig. 7F). However, there were no changes in the
maximal activities of the following enzymes: PHOS, PFK,
HADH, and CS. Interestingly, on the LF diet, C3 KO cardiac
AMPK activity was also significantly lower than in WT mice
(P  0.0006; Fig. 7D).
Fig. 3. C3 KO mice on HF diet have increased ex vivo palmitate oxidation and
greater CD36 content in skeletal muscle. A: ex vivo fatty acid palmitate
oxidation is increased in C3 KO mice, as measured in quadriceps muscle of C3
KO and WT mice. CD36 content (B) was evaluated by Western blot, and
carnitine palmitoyltransferase I (CPT I) maximal activity (C) was assessed in
muscle homogenates. All results are expressed as means  SE in WT mice
(open bars) and C3 KO mice (black bars) on the HF diet for n  6–8
mice/group, where *P  0.05 and **P  0.01.
Table 2. Markers of glycolysis, fatty acid oxidation, and
energy metabolism in skeletal muscle of C3 KO and WT
mice on the LF diet
WT C3 KO
Glycogen, mol/g 34.193.02 17.483.88†
PHOS, mol min1 g1 29.192.70 26.101.26
HK, mol min1 g1 1.230.16 1.130.12
PFK, mol min1 g1 17.002.03 25.692.50*
GAPDH, mol min1 g1 438.033.5 466.124.1
CD36, arbitrary units 86.046.56 66.0810.03
CPT I, mol min1 g1 0.1300.005 0.1560.015
HADH, mol min1 g1 9.981.43 14.120.68*
Cyto c, % of WT LF 100.0%37.05 70.12%29.56
CS, mol min1 g1 9.590.98 13.741.33*
AMPK, nmol min1 g1 0.0370.007 0.0460.006
CK, mol min1 g1 661.050.3 569.321.8
COX, mol min1 g1 3.040.36 3.840.41
Heart AMPK, nmol min1 g1 0.080.01 0.040.005
Results are expressed as means  SE for 6–8 mice. PHOS, glycogen
phosphorylase; HK, hexokinase; PFK, phosphofructokinase; CPT I, carnitine
palmitoyltransferase I; HADH, hydroxyacyl-CoA dehydrogenase; Cyto c,
cytochrome c; CS, citrate synthase; AMPK, AMP-activated protein kinase;
CK, creatine kinase; COX, cytochrome c oxidase. Significance was determined
by t-test comparing WT vs. KO, where *P  0.05 and †P  0.01.
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DISCUSSION
C3 KO mice, on either a LF or HF diet, demonstrated higher
food intake while maintaining similar body weight to WT
mice. Interestingly, these results were not associated with
significant differences in leptin, insulin, or adiponectin levels,
hormones known to influence energy metabolism, suggesting a
process directly related to the absence of ASP. Furthermore, in
BAT, a source of energy expenditure through UCPs (3), no
differences were observed in BAT weight, and we previously
reported downregulation of UCP1 (39). This implies that the
imbalance in caloric intake between the C3 KO and the WT
mice is controlled by a mechanism unrelated to BAT activa-
tion.
Skeletal muscle represents 	38% of total body weight in
both mice and humans (2) and plays an important role in fuel
storage and utilization. In the present study, we observed a
rearrangement of the metabolic machinery that favors fatty
acid oxidation in C3 KO mice skeletal muscle. This was seen
under both diets but was more pronounced in the HF diet. On
the LF diet, differences in substrate use were demonstrated by
delayed glucose clearance, lower muscle glycogen content, and
increased HADH and citrate synthase activities in the quadri-
ceps muscle. On the HF diet, the ASP-deficient mice showed a
similar shift in metabolic potential toward fatty acid oxidation
in the quadriceps muscle. This was demonstrated by a lower
RQ, lower ex vivo glucose oxidation, higher ex vivo fatty acid
oxidation, and lower muscle glycogen content. In addition, the
maximal activities of four key glycolytic enzymes (PHOS, HK,
PFK, and GAPDH) decreased, whereas HADH activity in-
creased, as did CD36 and cytochrome c content in C3 KO
mice. Last, the lower PFK/HADH ratio further supports the
shift in metabolic potential from glucose oxidation toward lipid
utilization (13). However, these differences appear to be me-
diated through both increased mitochondrial activity and con-
tent.
In our previous studies on the ASP-C5L2 pathway, we found
that the C3 KO mice had increased food intake, delayed
postprandial TG clearance, elevated oxygen consumption and
increased fatty acid uptake, and oxidation in muscle after a fat
load (24, 25, 39). Similar results were recently obtained in
C5L2 KO mice, which are ASP receptor-deficient mice (28).
Fig. 4. Increased potential for mitochondrial metabolism in skeletal muscle of
C3 KO mice on a HF diet. A: C3 KO mice on HF diet had increased
hydroxyacyl-CoA dehydrogenase (HADH) maximal activity. B: C3 KO mice
also demonstrated increased cytochrome c content. C: the switch in the
potential for metabolic fuel utilization in C3 KO mice is indicated by the
decrease in ratio of PFK/HADH activities. Results are expressed as means 
SE; n  6–8 mice in each case, where *P  0.05 and **P  0.01.
Fig. 5. Decreased AMP kinase (AMPK) and creatine kinase (CK) activities in
C3 KO mice on a HF diet. A: C3 KO mice have decreased maximal AMPK
activity. B: for the same diet, CK activity is also decreased in the C3 KO.
Results are expressed as means  SE; n  6–8 mice in each group, where
**P  0.01 and ***P  0.001.
Table 3. Relative potential for pathways of energy
metabolism expressed as ratios of enzymes involved
in glucose and fatty acid oxidation in skeletal muscle
Ratios WT LF C3 KO LF WT HF C3 KO HF
PFK/CS 1.720.36 1.940.29 2.320.50 1.440.35
PFK/HADH 2.060.45 1.940.30 2.040.31 1.140.17*
PFK/COX 5.970.86 7.020.83 9.432.11 6.281.94
Results are expressed as means  SE (in mol) for 6–8 mice, where signifi-
cance was determined by t-test comparing WT vs. KO, where *P  0.05.
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The influence of the ASP-C5L2 pathway on energy expendi-
ture was also evaluated in double-knockout leptin-deficient
ob/ob and ASP-deficient mice. Strikingly, the lack of ASP in
ob/ob mice reduced weight gain, improved insulin sensitivity,
and increased energy expenditure (38). The imbalance be-
tween energy intake and energy expenditure could not be
explained by increased physical activity or obvious changes
in body temperature; however, the data were consistent with
increased muscle fatty acid metabolism (38). Altogether, the
previous studies support the hypothesis that mice lacking
Fig. 6. Controlled food intake leads to de-
creased body weight, insulin level, and adi-
ponectin level in C3 KO mice. A: studies on
pair-fed mice show that C3 KO mice with food
intake maintained at the level of WT mice
have a lower body weight. Body weight was
measured over a 12-wk period for WT mice
(), C3 KO mice (F), and C3 KO pair-fed (PF)
mice (Œ), where P  0.0001 by linear regres-
sion analysis between PF C3 KO and WT
mice. Plasma levels of insulin (B) and adi-
ponectin (C) were lower in PF C3 KO mice vs.
WT. D: protein levels of mitochrondrial tran-
scription factor A (mtTFA), peroxisome pro-
liferator-activated receptor- (PPAR), un-
coupling protein 3 (UCP3), and cytochrome c
(Cyto c) were assayed by Western blot. PF C3
KO mice showed increased UCP3 and cyto-
chrome c. Results are expressed as means  SE;
n  4–8 mice in each case, where *P  0.05.
Fig. 7. Cardiac muscle ex vivo oxidation and maximal
enzyme activities in C3 KO mice on a HF diet. Ex vivo
glucose (A) and fatty acid palmitate (B) oxidation were
measured in heart tissue. No significant changes were
present in glucose oxidation for the C3 KO mice, whereas
an increase in fatty acid palmitate oxidation was observed
in these mice. Cardiac muscle from C3 KO mice demon-
strated decreased CK (C), AMPK (D), and CPT I (E)
maximal activities. GAPDH activity (F) was increased in
the C3 KO mice on the HF diet. Results are expressed as
means  SE; n  6–8 mice in each case, where *P 
0.05, **P  0.01, and ***P  0.001.
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ASP (C3 KO) or C5L2 signaling display increased energy
expenditure.
The present study directly addresses the mechanism under-
lying this altered energy expenditure. We observed, through
examination of the glycolytic and fatty acid oxidation path-
ways in the muscle, that mice lacking a functional ASP-C5L2
pathway (C3 KO) have increased energy expenditure through
increased oxygen consumption and display a preference for
fatty acids as a substrate over carbohydrates. The shift is
indicated by increased fatty acid oxidation, higher CD36 con-
tent, and increased HADH activity. Decrease in glucose oxi-
dation capacities and activities of glycolytic enzymes further
supports the substrate preference.
The mechanism of increased fatty acid oxidation in the
muscle of C3 KO mice may derive from an increased diversion
of substrate (fatty acids) away from adipose tissue and toward
muscle. Our previous work showed that the C3 KO mice had
excess circulating lipid availability associated with delayed
postprandial TG and NEFA clearance (24, 25, 39). The effect
of substrate availability on oxidation is supported by recent
data in C57BL/6 mice, db/db mice, and obese rats showing that
excess lipid availability due to a HF diet resulted in increased
ex vivo muscle fatty acid oxidation and activation of major
-oxidation enzymes (35). The increased lipid accessibility
was also associated with impaired glucose clearance as well as
impaired insulin action (35).
The increased fatty acid muscle metabolism in C3 KO mice
may be substrate driven (as discussed above), resulting in a
corresponding decrease activity in the glycolytic pathway. The
increase in fasting glucose, with a trend for increased insulin,
would also be consistent with an overload of fat to the muscle,
leading to insulin resistance. In the present study, ex vivo
glucose oxidation was decreased, glucose clearance was de-
layed, glycogen reserves were decreased, and phosphofructose
kinase activity was downregulated. All of these are consistent
with the inhibitory effect of increased fatty acid oxidation on
the glycolytic pathway, detailed a number of years ago as the
Randle cycle, which states that substrate competition is dom-
inated by fatty acids, which can inhibit (via citrate accumula-
tion) glycolysis (31). HF diet consumption has also been
shown to reduce muscle glycogen levels (17). Furthermore, the
switch in metabolic substrate has been well described in studies
on fasting and exercise, which have shown a profound prefer-
ence toward fatty acid utilization due to diminished glucose
availability (5).
Substrate diversion and alterations in muscle metabolism
have also been identified in a number of other mouse knockout
models. Acetyl-CoA carboxylase-2-deficient mice (ACC2 KO)
and stearoyl-CoA desaturase-1-deficient mice (SCD1 KO) are
two examples of KO mice that show many similar character-
istics (although not all) to the C3 KO and C5L2 KO mice. In
both cases, the mice have a lean phenotype with enhanced fatty
acid oxidation and increased metabolic rate coupled to in-
creased food intake (1, 6, 7, 26). On average, SCD1 KO mice
consume 25% more food that their WT counterparts without
accumulating fat, thus making them resistant to diet-induced
obesity. SCD1 KO mice have higher rates of oxygen consump-
tion, and genes involved in -oxidation were shown to be
upregulated (7). One striking difference between ACC2 KO
and SCD1 KO mice and the C3 KO mice is the increase in
AMPK activity related to the elevated energy expenditure.
C3 KO mice display reduced AMPK activity in both skeletal
and cardiac muscle on a HF diet. AMPK is commonly referred
to as the cell’s fuel regulator, sensing disturbances in energy
requirements (ATP/AMP) (15). In response to low cellular
ATP, AMPK activates both fatty acid oxidative and glycolytic
enzymes to replenish energy stores while downregulating an-
abolic pathways such as fatty acid synthesis (15). AMPK is
highly regulated by a number of hormones, physiological
conditions, and pharmacological agents. Studies have shown
that skeletal muscle AMPK is downregulated in trained rats
during acute exercise, with age, and HF diet consumption (9,
20, 32). Recently, Wu et al. (37) demonstrated that chronic
palmitate exposure inhibited endothelial AMPK phosphoryla-
tion and activity. Therefore, the elevated postprandial plasma
NEFA observed in C3 KO mice (23, 24, 39) could contribute,
by the pathway described above, to the reduced AMPK activ-
ities observed in the present study.
On the other hand, the higher energy expenditure in C3 KO
mice could be attributed to a direct lack of ASP-C5L2 signal-
ing in the muscle. C5L2 is highly expressed in muscle tissue
(Ref. 27 and Roy C, personal observation), and ASP has been
shown to stimulate glucose transport in muscle L6 cells (34).
Both C3 KO and C5L2 KO mice demonstrate delayed glucose
clearance after a challenge with a glucose tolerance test (28).
Therefore, a lack of ASP stimulation of muscle glucose uptake
(and increased fatty acid availability due to inefficient adipose
storage) may drive the enhanced lipid oxidation. This is sup-
ported by the results obtained when hyperphagia in the C3 KO
mice is controlled, where C3 KO mice body weight is lower
than that of their WT counterparts.
The importance of the ASP-C5L2 pathway is highlighted in
its regulation of fatty acid metabolism. Inhibition of the path-
way leads to excess plasma lipid availability that increases
mitochondrial -oxidation capacity in muscle and overall en-
ergy expenditure. On the other hand, an increase in plasma
fatty acids, particularly in humans, may lead to undesirable
effects (i.e., inducing insulin resistance). One of the most
salient concerns with delaying dietary lipid clearance is the
potential for increased TG delivery to the liver leading to
increased lipoprotein production, which is a risk for metabolic
syndrome (30). The increased food intake noted in the C3 KO
mice may also be an undesirable side effect when blockage of
ASP-C5L2 as a potential obesity target is considered. Further
studies are necessary to determine the outcome of both acute
and chronic ASP-C5L2 blocking in obese mouse models to
provide better data on how these side effects may be mitigated.
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